# DCI Donor Services – FDA Inspection, Apr 10, 2025

Source: https://www.keypedia.com/records/fda_inspections/dci-donor-services/b34ececc-be71-4d5d-9e92-1ff31d829e90
Source feed: FDA_Inspections

> FDA inspection 1266880 of DCI Donor Services, April 10, 2025. Classification: No Action Indicated (NAI). 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1266880
- Company Name: DCI Donor Services
- Inspection Date: 2025-04-10
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1151792 - 2021-08-31
- [FDA Inspection 1113338 - 2019-12-19](https://www.keypedia.com/records/fda_inspections/dci-donor-services/7940fb1a-ba60-4b73-9172-6309fa04be2f)
- FDA Inspection 1034911 - 2017-11-17
- FDA Inspection 958227 - 2015-12-14
- FDA Inspection 890360 - 2014-08-08

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/shelley-h-beausoleil/1212116b-e24d-4bbc-a27a-5c16334d573e)

Company: https://www.keypedia.com/companies/dci-donor-services/773b247c-d86c-4dbc-af92-f050f5188181

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d